2Anavekar N S,Mc Murray J J,Velazquez E J,et al.Relation between renal dysfunction and caediovascular outcomes after myocardial infarction.N Engl J Med.2004,351:1285 被引量：1
3Jung K,Jung M.Cystatin C:a promising marker of glomerular filtration rate to replace creatitine,Nephron,1995,70:370 被引量：1
4Newman D J,Thakkar H,Edwards R G,et al.Serum cystatin C measured by automated immunoassay:a more sensistive marker of changes in GFR than serum creatitine.Kidney Int,1995,47:312 被引量：1
5J H IX,M G Shlipak,G M Chertow,et al.Association of Cystatin C with Mortality,Cardiovascular Events,and Incident Heart Failure Among Persons With Coronary Heart Disease:Date From the Heart and Soul Study.Circulation,Janyary 16,2007;115(2):173 被引量：1
6Laterza O F,Price C P,Scott M G.Cystatin C:an improved estimater of glomerular filtration rate?Clin Chem.2002,48:699 被引量：1
8Jernberg T,Lindahl B,James S,et al.Cystatin C:a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome.Circulation,2004,110:2342 被引量：1
9Pinkan T,Hilgers K F,Veelken R,et al.How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease.J Am Soc Nephrol,2004,15(3):517 被引量：1
10Fliser D,Kielstein J T,Bode-Boger S M,et al.Asymmetric dimethylarginine(ADMA):a cardiovascular risk factor in patients with renal disease.Kidney Int,2003,63(Suppl 84):S37 被引量：1
2Foley RN, Parfrey PS, Sarnak MJ.Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis,1998,32(5 Suppl 3):S112-S119. 被引量：1
3Witko-Sarsat V, Friedlander M, Capeillere-Blandin C,et al.Advanced oxidation protein products as a novel marker of oxidative stress in uremia.Kidney Int, 1996,49:1304-1313. 被引量：1
4Witko-Sarsat V, Friedlander M, Nguyen Khoa T,et al.Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.J Immunol,1998,161:2524-2532. 被引量：1
5Stein G, Busch M, Muller A, et al.Are advanced glycation end products cardiovascular risk factors in patients with CRF?Am J Kidney Dis,2003,41(3 Suppl 1):S52-S56. 被引量：1
6Craven TE, Ryu JE, Espeland MA,et al.Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.Circulation,1990,82:1230-1242. 被引量：1
7Stenvinkel P, Heimburger O, Paultre F,et al.Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.Kidney Int,1999,55:1899-1911. 被引量：1
8Kaneda H, Taguchi J, Ogasawara K, et al.Increased level of advanced oxidation protein products in patients with coronary artery disease.Atherosclerosis,2002,162:221-225. 被引量：1
9Schomin M, EIcnhardt A, Rita E. The micro-inflammatory state of uremia. Blood Purif,2000,18:327-332. 被引量：1
10Santoro A, Mancini E.Cardiac effects of chronic inflammation in dialysis patients.Nephrol Dial Transplant,2002,17 Suppl 8:10-15. 被引量：1
